Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims against the board of directors of Immucor, Inc. (“Immucor” or the “Company”) (NASDAQ: BLUD) concerning possible breaches of fiduciary duty and other violations of law related to the Company's agreement to be acquired by TPG Capital (“TPG”) in a transaction valued at approximately $1.973 billion. On July 5, 2011, Immucor announced that it had entered into a definitive merger agreement under which the Company would be acquired by investment funds managed by TPG pursuant to which Immucor shareholders will receive $27.00 in cash for each share of Immucor they own. Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by the Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of Immucor. At least one analyst has set a target price for the Company’s shares at $28.00 per share. If you own shares of Immucor and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Daniella Quitt toll free at (877) 935-7400 or to sign up online, visit www.hfesq.com. You may also email Ms. Quitt at firstname.lastname@example.org. For more information about class action cases in general, please visit our website: www.hfesq.com. Harwood Feffer LLP is a national shareholder litigation firm. Harwood Feffer LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. Attorney Advertising. (C) 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.